@Helleofabore
Let's have a look at that study you have posted. Many of us have seen it and read it. Did you? Did you really?
The baseline Z-scores in the trans boys were better with average areal BMD Z-score 0.17 ± 1.18, BMAD Z-score 0.28 ± 0.90). However, Z-scores in the trans boys also showed an expected drop during GnRHa treatment. Similarly, they did not fully Bmake up their bone loss as Z-scores at age 22 were still lower than baseline (aBMD Z-score − 0.33 ± 1.12 and BMAD Z-score average − 0.033 ± 0.95), despitea small increase in absolute aBMD. One transman at age 22 had a Z-score of < −2.0.^
Just to be sure....
Similarly, they did not fully Bmake up^ their bone loss as Z-scores at age 22 were still lower than baseline (aBMD Z-score − 0.33 ± 1.12 and BMAD Z-score average − 0.033 ± 0.95), despitea small increase in absolute aBMD. One transman at age 22 had a Z-score of < −2.0.
And
This group also reported on bone density and turnover markers in a trial of adolescents/young adults [50] (median age 13.5 range 11.5–18.3) which included some overlapping study participants treated with GnRHa followed by GAHT. In both the young trans men and trans women BMAD Z-scores decreased during treatment with GnRHa and increased after initiation of GAHT but remained below the population average and below baseline levels even after 24 months of GAHT. They also looked at bone turnover markers, which did not completely correlate with DXA findings. GnRHa resulted in lower formation and resorption markers, as measured by P1NP and ICTP, which is consistent with GnRHa use in cis adolescents. Despite initiation of GAHT, these markers continued to decrease although BMAD increased as described above. This may be in line with findings at the end of puberty, but many require further study as to the impact of other hormones or lifestyle on bone health in young trans adults.
Are you sure what you read?
Sorry, I got distracted and pressed submit too soon.
So, your claim was
they have done a study on trans men who were given puberty blockers as girls. Bone scans have shown that their pelvises do not expand into the usual female wider shape and configuration, but remain narrow like a males pelivis. It’s why there are fertility and childbirth complications in transmen, they are more likely to require a c-section due to this nonfemale narrow pelvis. Their limbs also show higher bone density...which would in an archaeological setting be called “robust” bones...more indicative of a man.
Their limbs also show higher bone density...which would in an archaeological setting be called “robust” bones...more indicative of a man.
ie. females taking PBs and then Testosterone have “robust” bones...more indicative of a man.
To which we have told you is bullshit.
Your study even tells you this is a bullshit claim. There are gender clinic specialists stating just how dangerous PBs are to bone density.
To be clear. As other PPs have stated.
The danger is that females do NOT gain the bone density they need during a blocked puberty. They then get some effect but not reliably enough density to put them to where they should be.
Please tell us what WE are not understanding and what YOU understand better.